Effective Targeted Chemoprophylaxis of Recurrent Liver Echinococcosis with Haplotype CYP1A2F1*A/A: a Clinical Case
Background. One of the main longterm quality criteria for treatment and prevention of echinococcosis is postoperative relapse, which rate varies widely within 3–54% between medical facilities. The genetic traits of recurrent liver echinococcosis comprise an important subject of research into its et...
Saved in:
Main Authors: | V. S. Panteleev, M. A. Nartaylakov, M. I. Lukmanov, G. I. Lukmanova |
---|---|
Format: | Article |
Language: | English |
Published: |
Bashkir State Medical University
2020-12-01
|
Series: | Креативная хирургия и онкология |
Subjects: | |
Online Access: | https://www.surgonco.ru/jour/article/view/530 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RETRACTED: Anti-relapse chemotherapy in liver echinococcosis
by: A. F. Chernousov, et al.
Published: (2016-12-01) -
Diagnosis and surgical treatment of liver echinococcosis
by: V.O. Shaprinskyi , et al.
Published: (2021-12-01) -
Radical treatment of liver echinococcosis. State of art
by: V. A. Vishnevsky, et al.
Published: (2007-09-01) -
SURGICAL TREATMENT OF HEPATIC ECHINOCOCCOSIS
by: G. D. Odishelashvili, et al.
Published: (2014-12-01) -
A case of alveolar echinococcosis in the liver that ruptured into the pericardium treated by a combination of hepatectomy and albendazole
by: Yoichi Yamamoto, et al.
Published: (2022-04-01)